New hope for Hard-to-Treat lung cancer: which combo works best?
NCT ID NCT05689671
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two different chemotherapy plus immunotherapy combinations in people with advanced lung cancer that has a specific marker (TTF-1 negative). About 136 participants will be randomly assigned to one of two treatment groups. The goal is to see which combination helps people live longer and controls the cancer better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Asklepios Klinik Gauting GmbH
Gauting, 82131, Germany
-
Asklepios Klinkum Hamburg
Hamburg, 21075, Germany
-
Barmherzige Brüder Krankenhaus Regensburg
Regensburg, 93049, Germany
-
Charité Universitätsmedizin
Berlin, 13353, Germany
-
Elblandkliniken Stiftung & Co. KG Elblandklinikum Riesa
Riesa, 01589, Germany
-
Evangelische Lungenklinik
Berlin, 13125, Germany
-
Evangelische Lungenklinik Krankenhausbetriebs gGmbH
Berlin, 13125, Germany
-
Helios Klinikum Emil von Behring
Berlin, 14165, Germany
-
Helios Klinikum Krefeld
Krefeld, 47805, Germany
-
KEM Evang. Kliniken Essen-Mitte
Essen, 45136, Germany
-
Kliniken der Stadt Köln GmbH
Cologne, 51109, Germany
-
Klinikum Bielefeld
Bielefeld, 33604, Germany
-
Klinikum Esslingen GmbH
Esslingen am Neckar, 73730, Germany
-
Klinikum Lippe GmbH
Lemgo, 32657, Germany
-
Klinikum Ludwigsburg
Ludwigsburg, 71640, Germany
-
Klinikum St. Marien
Amberg, 92224, Germany
-
Klinikum Stuttgart
Stuttgart, 70174, Germany
-
Krankenhaus Nordwest
Frankfurt, 60488, Germany
-
LMU Klinikum
München, 80336, Germany
-
LungenClinic Großhansdorf GmbH
Großhansdorf, 22927, Germany
-
Lungenklinik Hemer
Hemer, 58675, Germany
-
MVZ Taunus GmbH
Bad Homburg, 61352, Germany
-
MVZ für Hämatologie und Onkologie Ravensburg GmbH
Ravensburg, 88212, Germany
-
Medizinische Fakultät Mannheim der Universität Heidelberg
Mannheim, 68167, Germany
-
Pius Hospital
Oldenburg, 26121, Germany
-
Technische Universität Dresden Medizinische Fakultät Carl Gustav Carus
Dresden, 01307, Germany
-
Thoraxklinik Heidelberg gGmbH
Heidelberg, 69126, Germany
-
Thoraxzentrum Ruhrgebiet Ev. Krankenhaus Herne
Herne, 44651, Germany
-
UKSH, Campus Lübeck
Lübeck, 23538, Germany
-
Universitätsklinikum Augsburg
Augsburg, 86156, Germany
-
Universitätsklinikum Essen
Essen, 45122, Germany
-
Universitätsklinikum Frankfurt am Main
Frankfurt am Main, 60590, Germany
-
Universitätsmedizin Göttingen
Göttingen, 37075, Germany
-
Unversitätsklinikum Münster
Münster, 48149, Germany
-
ÜBAG- Medizinisches Versorgungszentrum Dr. Vehling-Kaiser GmbH
Landshut, 84036, Germany
-
Überörtliche Gemeinschaftspraxis für Hämatologie und Onkologie
Münster, 48153, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a triple-drug cocktail re-sensitize lung cancer to treatment?
- Could a lung cancer drug designed for one mutation work for another?
- Could chemo plus immunotherapy double the punch against tough lung cancers?
- Should all advanced lung cancer patients get a brain scan? new trial aims to find out
- New hope for tough lung cancer? trial tests targeted drug against chemo
- New combo therapy for lung cancer under Real-World watch